Imagion Biosystems Limited (ASX:IBX) has requested a trading halt for its ordinary shares on the Australian Securities Exchange (ASX) in relation to a proposed capital raising. The trading halt is expected to remain in place until the earlier of the commencement of normal trading on Thursday, 10 October 2024, or when the announcement regarding the proposed capital raising is made.
The trading halt has been requested to manage the continuous disclosure obligations as the company prepares to make a material announcement to the market regarding the proposed capital raising. The company is not aware of any reason why the trading halt should not be granted or of any further information necessary to inform the market about the trading halt.
Imagion Biosystems Limited (ASX:IBX) has requested a trading halt in preparation for a material announcement regarding a proposed capital raising. The company aims to manage its continuous disclosure obligations and expects the trading halt to be lifted upon the announcement or by the commencement of normal trading on Thursday, 10 October 2024. The request indicates the company's proactive approach to ensuring compliance with ASX Listing Rule 17.1 and its commitment to transparent communication with the market.